Amgen Inc. (AMGN)
NASDAQ: AMGN · Real-Time Price · USD
289.33
+4.35 (1.53%)
At close: Aug 13, 2025, 4:00 PM
289.24
-0.09 (-0.03%)
After-hours: Aug 13, 2025, 7:59 PM EDT
Amgen Market Cap
Amgen has a market cap or net worth of $155.76 billion as of August 13, 2025. Its market cap has decreased by -12.67% in one year.
Market Cap
155.76B
Enterprise Value
203.94B
1-Year Change
-12.67%
Ranking
Category
Stock Price
$289.33
Market Cap Chart
Since December 1, 1998, Amgen's market cap has increased from $19.50B to $155.76B, an increase of 698.68%. That is a compound annual growth rate of 8.09%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 13, 2025 | 155.76B | 11.18% |
Dec 31, 2024 | 140.10B | -9.11% |
Dec 29, 2023 | 154.14B | 9.99% |
Dec 30, 2022 | 140.14B | 10.59% |
Dec 31, 2021 | 126.72B | -5.33% |
Dec 31, 2020 | 133.85B | -6.55% |
Dec 31, 2019 | 143.24B | 15.47% |
Dec 31, 2018 | 124.05B | -1.73% |
Dec 29, 2017 | 126.24B | 16.06% |
Dec 30, 2016 | 108.77B | -11.17% |
Dec 31, 2015 | 122.45B | 1.06% |
Dec 31, 2014 | 121.17B | 40.84% |
Dec 31, 2013 | 86.03B | 30.06% |
Dec 31, 2012 | 66.15B | 17.52% |
Dec 30, 2011 | 56.28B | 8.51% |
Dec 31, 2010 | 51.87B | -9.41% |
Dec 31, 2009 | 57.26B | -6.42% |
Dec 31, 2008 | 61.19B | 21.14% |
Dec 31, 2007 | 50.51B | -36.61% |
Dec 29, 2006 | 79.68B | -18.14% |
Dec 30, 2005 | 97.34B | 19.46% |
Dec 31, 2004 | 81.48B | 2.22% |
Dec 31, 2003 | 79.71B | 28.11% |
Dec 31, 2002 | 62.22B | 5.44% |
Dec 31, 2001 | 59.01B | -10.66% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 574.04B |
Johnson & Johnson | 416.11B |
AbbVie | 350.91B |
UnitedHealth Group | 236.90B |
AstraZeneca | 232.33B |
Novartis AG | 230.64B |
Abbott Laboratories | 228.03B |
Novo Nordisk | 223.00B |